Insider · CIK 0001073384
Joseph H Wender
Files at IONS (IONIS PHARMACEUTICALS INC), OUT (OUTFRONT Media Inc.). First filing Sep 4, 2025, latest Dec 3, 2025.
In brief
Joseph H Wender files SEC Form 4 as director at IONS (IONIS PHARMACEUTICALS INC), and also at OUT (OUTFRONT Media Inc.). Since Sep 4, 2025, Joseph H Wender has reported 0 open-market buys worth $0 and 5 open-market sells worth $8.7M, the latest filed on Dec 3, 2025.
A track record needs three past buys with six months of prices behind them; Joseph H Wender has 0, so none is measured yet.
The newest scored trade: sold $2.3M of IONS on Dec 1, 2025, filed Dec 3, 2025, scored 45 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $4.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | IONIS PHARMACEUTICALS INC | $2.3M 28,000 shares | -44% | +221% from low-1% from high | |
| 45Moderate | IONIS PHARMACEUTICALS INC | $2.1M 28,000 shares | -30% | +191% from low0% from high | |
| 40Moderate | IONIS PHARMACEUTICALS INC | $1.1M 16,800 shares | -15% | +158% from low0% from high | |
| 40Moderate | IONIS PHARMACEUTICALS INC | $1.6M 28,000 shares | -20% | +125% from low0% from high | |
| 40Moderate | IONIS PHARMACEUTICALS INC | $1.6M 28,000 shares | -20% | +125% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 1, 2025 | IONS Ionis Pharmaceuticals, Inc. | 14,479 0.01% of outstanding | $1.2M | Dec 1, 2025 | $6.1M |
| Oct 30, 2025 | IONS Ionis Pharmaceuticals, Inc. | 33,600 0.02% of outstanding | $2.5M | Oct 30, 2025 | $3.5M |
| Oct 1, 2025 | IONS Ionis Pharmaceuticals, Inc. | 22,400 0.01% of outstanding | $1.5M | Oct 1, 2025 | $2.0M |
| Sep 2, 2025 | IONS Ionis Pharmaceuticals, Inc. | 33,600 0.02% of outstanding | $1.9M | Sep 2, 2025 | none |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -20,571 | $80.67 | $1.7M | 43,464 | Dec 3, 2025 |
| Dec 1, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -7,429 | $81.23 | $603k | 36,035 | Dec 3, 2025 |
| Nov 18, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +16,000 | $24.42 | $391k | 16,000 | Nov 20, 2025 |
| Nov 18, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -16,000 | $0.00 | $0 | 0 | Nov 20, 2025 |
| Oct 30, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -2,484 | $72.19 | $179k | 89,551 | Nov 3, 2025 |
| Oct 30, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -8,341 | $73.16 | $610k | 81,210 | Nov 3, 2025 |
| Oct 30, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -5,975 | $73.85 | $441k | 75,235 | Nov 3, 2025 |
| Oct 31, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -11,200 | $75.16 | $842k | 64,035 | Nov 3, 2025 |
| Oct 1, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -16,800 | $65.50 | $1.1M | 92,035 | Oct 2, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -11,200 | $55.04 | $616k | 125,635 | Sep 4, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -11,200 | $55.04 | $616k | 125,635 | Sep 4, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -5,600 | $57.53 | $322k | 120,035 | Sep 4, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -5,600 | $57.53 | $322k | 120,035 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -11,200 | $60.14 | $674k | 108,835 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -11,200 | $60.14 | $674k | 108,835 | Sep 4, 2025 |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stockindirect: by Trust | +4,079 | $0.00 | $0 | 136,835 | Jul 17, 2025 |
| Jul 15, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -4,079 | $0.00 | $0 | 1,141 | Jul 17, 2025 |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +11,518 | $0.00 | $0 | 11,518 | Jul 2, 2025 |
| Jul 1, 2025 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +5,220 | $0.00 | $0 | 9,299 | Jul 2, 2025 |
| Jun 3, 2025 | OUT OUTFRONT Media Inc. | MOption exercise Common Stock | +10,125 | $0.00 | $0 | 69,225 | Jun 5, 2025 |
| Jun 3, 2025 | OUT OUTFRONT Media Inc. | AGrant or award Common Stock | +771 | $0.00 | $0 | 69,996 | Jun 5, 2025 |
| Jun 3, 2025 | OUT OUTFRONT Media Inc. | MOption exercise Restricted Share Unitsderivative | -10,125 | $0.00 | $0 | 0 | Jun 5, 2025 |
Questions about Joseph H Wender
Answered from the filings on this page, as of the latest one.
Is Joseph H Wender buying or selling?
In the last 12 months Joseph H Wender reported 0 open-market buys worth $0 and 2 open-market sells worth $4.3M on SEC Form 4; the latest was sold $2.3M of IONS on Dec 1, 2025. Grants, option exercises and tax withholding are not counted.
How did Joseph H Wender's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph H Wender has 0.
Where does Joseph H Wender file Form 4?
Joseph H Wender has filed Form 4 at IONS (IONIS PHARMACEUTICALS INC); OUT (OUTFRONT Media Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.